We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$204M
AUM Growth
+$15.9M
Cap. Flow
+$17.5M
Cap. Flow %
8.58%
Top 10 Hldgs %
6.14%
Holding
488
New
66
Increased
245
Reduced
135
Closed
40

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$976K
2
NFLX icon
Netflix
NFLX
+$953K
3
CRWD icon
CrowdStrike
CRWD
+$952K
4
RCL icon
Royal Caribbean
RCL
+$905K
5
TJX icon
TJX Companies
TJX
+$890K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.11M
2
LLY icon
Eli Lilly
LLY
+$937K
3
FCX icon
Freeport-McMoran
FCX
+$933K
4
ALGN icon
Align Technology
ALGN
+$933K
5
MLM icon
Martin Marietta Materials
MLM
+$930K

Sector Composition

Rank Sector Weight
1 Financials 26.66%
2 Healthcare 19.14%
3 Technology 17.16%
4 Energy 7.21%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLRN
351
DELISTED
ACELYRIN
SLRN
$91.6K 0.04%
20,763
+8,862
+74% +$41.5K
PTGX icon
352
Protagonist Therapeutics
PTGX
$8.64B
$91.3K 0.04%
2,635
-1,540
-37% -$45.1K
ARVN icon
353
Arvinas
ARVN
$523M
$91.1K 0.04%
3,423
+992
+41% +$31.6K
EWTX icon
354
Edgewise Therapeutics
EWTX
$4.29B
$91K 0.04%
+5,054
New +$88.2K
ARQT icon
355
Arcutis Biotherapeutics
ARQT
$3.48B
$90.1K 0.04%
+9,692
New +$87.6K
SVRA icon
356
Savara
SVRA
$1.08B
$89.9K 0.04%
+22,297
New +$99.2K
IMVT icon
357
Immunovant
IMVT
$8.01B
$89.8K 0.04%
3,403
+1,372
+68% +$39K
SNDX icon
358
Syndax Pharmaceuticals
SNDX
$1.73B
$89.8K 0.04%
4,373
+14
+0.3% +$293
ACLX
359
DELISTED
Arcellx
ACLX
$89.6K 0.04%
1,623
-65
-4% -$3.53K
VRDN icon
360
Viridian Therapeutics
VRDN
$2.15B
$89.6K 0.04%
6,884
+2,405
+54% +$33.3K
JANX icon
361
Janux Therapeutics
JANX
$902M
$89.5K 0.04%
+2,137
New +$100K
NAMS icon
362
NewAmsterdam Pharma
NAMS
$3.33B
$89.5K 0.04%
+4,657
New +$93.4K
NMRA icon
363
Neumora Therapeutics
NMRA
$306M
$89.4K 0.04%
9,098
+3,180
+54% +$32.9K
ARWR icon
364
Arrowhead Research
ARWR
$11.7B
$88.8K 0.04%
3,416
+385
+13% +$9.46K
ABUS icon
365
Arbutus Biopharma
ABUS
$871M
$88.5K 0.04%
+28,647
New +$85.9K
HLVX
366
DELISTED
HilleVax
HLVX
$88.5K 0.04%
+6,117
New +$84K
RVMD icon
367
Revolution Medicines
RVMD
$39.1B
$88.4K 0.04%
2,278
-1,033
-31% -$38.6K
NUVB icon
368
Nuvation Bio
NUVB
$2.25B
$88.4K 0.04%
+30,276
New +$92.4K
VERA icon
369
Vera Therapeutics
VERA
$2.42B
$87.6K 0.04%
2,420
-3,466
-59% -$137K
PRTA icon
370
Prothena Corp
PRTA
$440M
$87.4K 0.04%
4,236
+2,013
+91% +$43.6K
SMMT icon
371
Summit Therapeutics
SMMT
$9.89B
$87.3K 0.04%
11,190
-21,625
-66% -$117K
SLN
372
Silence Therapeutics
SLN
$517M
$87.2K 0.04%
+4,591
New +$97.6K
NUVL
373
DELISTED
Nuvalent
NUVL
$86.9K 0.04%
1,146
+50
+5% +$3.56K
DNTH icon
374
Dianthus Therapeutics
DNTH
$5.66B
$86.9K 0.04%
+3,358
New +$80.7K
CRGX
375
DELISTED
CARGO Therapeutics
CRGX
$86.5K 0.04%
+5,269
New +$100K
13 14
15
16 17

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus ETF Advisers held 488 positions worth $204M, up 8.5% from $188M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $17.5M of net new capital in Q2 2024, opening 66 new positions and adding to 245 existing holdings. Its largest new stake was Qualcomm: 5,165 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Extra Space Storage, an estimated $732K trimmed.

  • Virtus ETF Advisers's largest Q2 2024 buy was Qualcomm: 5,165 shares worth $1.03M.
  • Virtus ETF Advisers added most to EOG Resources in Q2 2024, an estimated $789K increase.
  • Virtus ETF Advisers's biggest Q2 2024 reduction was Extra Space Storage, cutting an estimated $732K.
  • Virtus ETF Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.11M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $204M portfolio in Q2 2024.
  • Virtus ETF Advisers opened 66 new positions and closed 40 in Q2 2024.
  • Virtus ETF Advisers's portfolio value rose 8.5% quarter-over-quarter to $204M.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.